Morepen Labs Share Price Surge Over 8% on August 13, 2026 Following 3-Day Decline

Morepen Laboratories' shares have climbed by almost 10% today, ending a 3-day losing streak where the stock had dropped over 8.5%. This uptick follows a prior gain of over 35% driven by strong June 2026 quarter results, as per news report. 

Upsurge in Morepen Labs Shares 

As of August 13, 2026, Morepen Laboratories' shares have surged by approximately 9%, marking an end to a 3-day period of losses. The company had seen its stock value decline by more than 8.5% earlier in the week.  

The share price had, however, witnessed over 35% growth from August 4 to August 7, driven by the company's positive financial results for the June quarter. 

The company reported a net profit of ₹56.4 crore, a significant increase from ₹10.8 crore the previous year. Additionally, the revenue for the quarter rose by 34.1% to ₹570.1 crore.  

The EBITDA witnessed a more than threefold rise to ₹82.5 crore from ₹24.2 crore, and the operating margin expanded to 14.5% from 5.7% in the same quarter last year. 

API Revenue Growth 

Morepen Laboratories experienced a 31% growth in active pharmaceutical ingredient (API) revenue. This was largely driven by a 42% rise in API exports due to an improved product mix and increased demand from international clients. Overall, the export revenue more than doubled, showing a year-on-year increase of 111%. 

Market Capitalisation and Shareholding 

The company's market capitalisation now stands at ₹4,402.81 crore. Promoters hold 35.65% of the company's stake, while foreign institutional investors (FIIs) control 1.46%, and domestic institutional investors (DIIs) have 1.29%. 

Read More: KPI Green Energy Share Price Falls Over 7% After Q1 FY27 Earnings Results: Total Income Up 15.6% YoY! 

Morepen Laboratories Share Price Performance  

As of August 13, 2026, at 11:57 AM, Morepen Laboratories share price on NSE was trading at ₹79.44, up by 8.14% from the previous closing price. 

Conclusion 

With a 9% rise today, Morepen Labs shares have made a recovery following a 3-day, 8.5% loss period. The stock performance has been bolstered by a 35% increase between August 4 and August 7, reflecting strong financial outcomes, including a jump in net profit to ₹56.4 crore and a 111% increase in export revenue. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.